Join the Search for New Lupus Treatments

Patient involvement in clinical research is critical to the development of more therapy options that better address the unique ways that lupus can affect people. Lupus Therapeutics is committed to ensuring that patients can participate in this work, ensuring approaches are truly patient-centric. Learn more about Lupus Therapeutics and the role that impactful engagement of patients can have.

Patient Advisory Boards (PABs)

By participating in a virtual or in-person PAB, patients can provide valuable feedback on clinical trial design and communications to ensure others living with lupus benefit from new treatments.

---

Patient Protocol Review Council

Individuals who participate in the Patient Protocol Review Council help Lupus Therapeutics’ clinical partners develop and update their clinical research trial designs and materials to be inclusive and acceptable to people with lupus.

---

Peer-to-Peer Education

Patient Advocates for Lupus Studies (PALS) is the first-ever peer-to-peer clinical trial education program. The PALS program aims to increase awareness, participation, and diversity in lupus clinical trials.

---

Community-Based Health Equity Initiatives

Lupus Therapeutics is spearheading several community-based initiatives to improve access to clinical trials, increase participation rates among diverse communities, and improve health equity for people with lupus.